C

Concarlo Therapeutics

7 employees

Concarlo Therapeutics is a preclinical-stage oncology company developing transformative therapeutics to target drug-resistant cancers.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Health Diagnostics
p27Kip1
Biotech
Therapeutics
Cancer Research
Drug-resistant Breast Cancer
Drug development
Breast Cancer

Date founded

2016

Funding rounds raised

Total raised

$7M

from 2 investors over 2 rounds

C

Concarlo Therapeutics raised $7M on March 19, 2018

Investors: Accelerate NY Seed Fund and New York State

FAQ